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We have developed sensitive and specific solid-phase radioimmunoassays to
quantitate the distribution and persistence of bacterial antigen in rats developing
arthritis in response to a single injection of streptococcal cell wall material. Three
separate assays were specific for either the A polysaccharide (N-acetyl-D-
glucosamine), A-variant polysaccharide (polyrhamnose), or peptidoglycan (D-ala-
D-ala) moieties of the streptococcal tell wall. Antigen was detected in all tissues
surveyed, although the greatest amount was in the liver and spleen. By using three
fractions of cell wall separated by size, we have shown that the development of
arthritis correlates with the degree of cell wall deposited and persisting in the
joints. Further statistical analyses suggested differences in metabolism by differ-
ent tissues and differential metabolism of different antigenic epitopes in some
cases.
A single intraperitoneal injection of an aque-
ous suspension of purified group A streptococ-
cal cell walls induces a chronic, progressive,
destructive polyarthritis in rats (2, 4, 5). The
disease is characterized by erosive synovitis of
the small joints of the fore- and hindlegs and
follows a clinical course of exacerbations and
remissions that resembles human rheumatoid
arthritis.
Our current understanding of the pathogenic
mechanisms involved in this animal model is as
follows. The purified cell wall consists of cova-
lently bound polymers of peptidoglycan and
group-specific polysaccharide. The peptidogly-
can moiety has the capability of inducing inflam-
mation (1), complement activation (8), and mac-
rophage activation (22). In addition, the cell wall
is relatively resistant to degradation in vivo,
probably because of the protective nature of the
group A polysaccharide (1, 19, 20). Immunofluo-
rescent studies of tissues taken from arthritic
rats document the persistence of cell wall anti-
gens (4, 5). Although dysfunction of several
facets of the immune system accompanies the
development ofjoint disease (described by J. H.
Schwab in S. Koatani, ed., Immunomodulation
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by Microbial Products and Related Synthetic
Compounds, in press), as yet no evidence direct-
ly implicates either cell-mediated immunity or
antibodies specific for cell wall antigens in the
mechanisms of tissue injury (9, 11).
To investigate quantitatively the relationship
of persistent streptococcal cell wall material to
the occurrence of arthritis, we have developed
highly sensitive and specific radioimmunoassays
(RIAs) that detect cell wall antigens and have
applied them to tissues from arthritic rats. An
earlier report (6) described the different clinical
patterns ofjoint disease produced with cell wall
fragments of different size. In this paper, the
quantitative assay is used to determine whether
these variations in the severity of acute and
chronic phases of joint inflammation, induced
with fragments of different size, can be related to
differences in tissue distribution and rate of
elimination. The results confirm that cell wall
material indeed persists, although it is slowly
catabolized over time. In addition, the severity
of arthritis correlates with the amount of cell
wall material present in the joint.
(A preliminary account of this work has ap-
peared in abstract form [Arthritis Rheum.
24(Suppl.):S64, 1981].)
MATERIALS AND METHODS
Induction and evaluation of arthritis. Outbred
Sprague-Dawley rats were purchased from Zivic-
Miller, Allison Park, Pa. Rats (8 weeks old), weighing
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approximately 100 g, were injected intraperitoneally
with a single dose of sterile cell wall fragments (30 j±g
of rhamnose per g of body weight or about 10 mg of
cell wall per rat) suspended in 0.1 M phosphate-
buffered saline (pH 7.2). Control rats were injected
with phosphate-buffered saline alone. Rats were
housed two to a cage and observed for clinical evi-
dence of arthritis daily over the first 2 weeks and 3
times a week thereafter. The severity of joint disease
in each limb was estimated on a scale of one to four
based on the degree of swelling, redness, and deformi-
ty (4).
Bacterial cell walls. A detailed description has been
presented previously (6). Briefly, group A, type 3,
strain D58 streptococci were processed by a combina-
tion of disruption, centrifugation, enzyme digestion,
solvent extraction, and sonication. The resulting mate-
rial was separated into three sizes of fractions by
differential centrifugation: 10P (10,000 x g pellet;
average molecular weight, 500 x 106); 100P (100,000 x
g pellet; average molecular weight, 50 x 106); and
100S (100,000 x g supernatant; average molecular
weight, 5.3 x 106) (6).
Processing of tissues. At 4, 29, and 65 days after cell
wall injection, groups of rats were killed by ether
anesthesia. The wrist and ankle joints, lungs, kidneys,
heart, spleen, liver, and blood were then harvested
and weighed in an aseptic manner. Skin was removed
from the joints, and the carpi or tarsi and surrounding
subcutaneous tissue were processed. All tissues were
kept frozen until extraction. For use in the RIA, the
tissues were suspended in 0.2 M Tris buffer (pH 8.0)
and homogenized individually in a Sorval Omnimixer
(E. I. duPont de Nemours & Co. Inc., Rockville, Md.)
for 15 min, with careful washing of the equipment
between samples. Samples were further treated by
heating to 100°C for 30 min in 0.2 M Tris buffer (pH
8.0) with 0.4% Nonidet P-40. Samples were again
frozen until assay time. Immediately before assay,
they were centrifuged at 1,000 rpm for 5 min to remove
tissue fragments. Samples of 24-h urine were collected
over the first 8 days after cell wall injection.
Antibodies. Rabbits were immunized with multiple
intravenous injections of group A streptococcal or
group A-variant streptococcal heat-killed, pepsin-
treated, whole cell vaccine. Three antibody specific-
ities were affinity purified from the resultant antisera
for use in RIAs. Anti-group A polysaccharide antibody
(anti-N-acetyl-D-glucosamine [NADG]) was affinity
purified from anti-group A antiserum on a column ofp-
aminophenyl-N-acetyl glucosamine bound to epoxy-
activated Sepharose (Pharmacia Fine Chemicals, Pis-
cataway, N.J.). Anti-A-variant polysaccharide was
affinity purified from anti-A-variant antiserum on a
column of purified A-variant polysaccharide bound to
the epoxy-activated Sepharose. It was further ab-
sorbed with columns of D-ala-D-ala-D-ala (Vega-Fox
Biochemicals Div., Tucson, Ariz.) and p-amino-
phenyl-NADG. Anti-peptidoglycan (anti-D-ala-D-ala)
antibody was affinity purified from anti-A-variant anti-
serum on a column of D-ala-D-ala-D-ala bound to
cyanogen bromide-activated Sepharose. F(ab')2 frag-
ments of each of these affinity-purified antibodies were
prepared by pepsin digestion, and undigested intact
immunoglobulin G (IgG) or pFc' fragments were thor-
oughly removed by a combination of gel filtration
(G150, Pharmacia Fine Chemicals) and absorption
with columns made of staphylococcal protein A (Phar-
macia Fine Chemicals) and sheep anti-rabbit IgG Fc
fragment. Sheep anti-rabbit IgG Fc was prepared by
extensive absorption of sheep anti-rabbit IgG on a
column of rabbit F(ab')2 fragments. This absorbed
antisera was then affinity purified on a rabbit IgG
column.
RIAs. The streptococcal cell wall material in rat
tissues was quantitated by three separate RIAs, using
each of the anti-cell wall specificities. Polyvinyl flexi-
ble plastic 96-well microtiter plates (Dynatech Labora-
tories, Inc., Alexandria, Va.) were coated with 100 RI
per well of 1 ,ug of the F(ab')2 fragment of anti-cell wall
antibodies per ml in 0.2 M Tris with 0.01% azide (pH
8.0) for 5 h at room temperature or overnight at 4°C.
Unbound material was then aspirated, and the plates
were nonspecifically coated with 200 RId of 0.5% sterile
human serum albumin in Tris buffer with 0.4% Tween
80 for 1 h. The coating solution was removed, and
tissue samples, which were diluted in the coating
buffer, were added for incubation overnight at 4°C.
The next day, intact IgG antibody of the same cell wall
specificity was added in coating buffer at a concentra-
tion of 5 ,ug/ml. After 3 h of incubation at 4°C, the
plates were again washed, and radioiodinated affinity-
purified sheep anti-rabbit Fc fragment (20,000 to
80,000 cpm/ng) was added for a further 2-h incubation.
After a final washing, the plates were dried, and the
wells were cut out for counting in an automatic gamma
scintillation counter (Searle Radiographics Inc., Chi-
cago, Ill.). Counts were recorded on teletype tape, and
data were processed by computer. Samples from a
given tissue from all rats at all time points were run in a
single assay, along with separate standard curves
made with the 10P, 100P, and 100S cell wall prepara-
tions. As it was found that the assays detect the 100S
preparation somewhat more efficiently than the 100P
or 10P preparations, cell wall quantitation in each rat
was derived by referring the counts obtained with a
particular tissue to the standard curve made with same
cell wall preparation used to inject the rat. The sensi-
tivity of the assays was approximately 10 pg per
sample (100 pg/ml). Negative samples were assumed
to contain 10 pg per well (i.e., loglo = 1) for the
purpose of calculations. With the exception of the
urines, as measured by the anti-D-ala assay, nearly all
tissues from uninjected control rats gave values below
background. Sporadic control samples showed values
just above background.
RESULTS
Assay specificities. The present understanding
of the structure of group A streptococcal cell
wall, derived from the studies of Karakawa et al.
(12), Schleifer and Krause (18), and Seidl and
Schleifer (21), is shown in Fig. 1. The numbers
indicate antigenic epitopes which have been
described. Our assays recognized the NADG
(GlcNAc, no. 1) moiety in the polysaccharide
(anti-A assay), the rhamnose oligosaccharide
([Rh-Rh] n, no. 2]) of the polysaccharide (anti-A
variant), and the D-ala-D-ala moiety (no. 5) of
the peptide side chain of the peptidoglycan (anti-
D-ala). Figure 2 demonstrates these specificities.
The anti-A assay (Fig. 2A) was inhibited by
INFECT. IMMUN.
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FIG. 1. Current understanding of the structure of
streptococcal cell wall. Numbers refer to known anti-
genic determinants. The radioimmunoassays used in
this work recognize the NADG of polysaccharide
(epitope 1, GlcNAc); A-variant polysaccharide (poly-
rhamnose; epitope 2, Rh-Rh); and the D-ala-D-ala end
of the pentapeptide side chain of the peptidoglycan
(epitope 5). MurNAc, N-Acetyl muramic acid.
purified NADG or purified A polysaccharide. A-
variant polysaccharide, which is known to lack
the terminal NADG groups (3), did not inhibit,
nor did monomeric rhamnose or the D-ala-D-ala
peptide. The anti-A-variant assay (Fig. 2B) was
markedly inhibited by both the A-variant poly-
saccharide and the A polysaccharide. It was also
partially inhibited by NADG, but not by D-ala-D-
ala or rhamnose. The anti-D-ala assay (Fig. 2C)
was fully inhibited by D-ala-D-ala, but not at all
by rhamnose or NADG. It was partially inhibit-
ed by A polysaccharide or A-variant polysac-
charide, suggesting that these polysaccharide
preparations may have been contaminated with
peptidoglycan. This possibility was supported
by other tests (data not shown) which indicated
that the binding of the anti-D-ala antibody to A
polysaccharide could be inhibited by the D-ala-
D-ala dipeptide and not by NADG.
Distribution of cell wail in rat tissues. The
quantity of cell wall material detected by each of
the three RIAs in rats injected 4 days previously
is tabulated in Table 1. Cell wall material was
found in all of the body parts surveyed. In
addition, the quantities of cell wall in a given
body part as judged by each of the three RIA
specificities were roughly comparable and tend-
ed to confirm each other (but see below). On day
4, the total amount of cell wall accounted for in
all of the body parts assayed amounted to ap-
proximately 1 mg compared with a total adminis-
tered dose of about 10 mg of cell wall per rat.
The initial distribution of cell wall in the front
and hind paws, liver, and spleen was statistically
compared for each assay and cell preparation by
a general linear cell mean model (10). Signifi-
cantly less 10P material was distributed to the
spleen and joints than either 100S or 100P. In
addition, more 100S material was generally pres-
ent than 100P, although these differences were
mostly not statistically significant. Finally, the
liver or spleen had significantly more cell wall
than the front or hind joints, whereas the liver
had more than the spleen, and the hind joints
had more than the front joints.
To determine whether cell wall material was
eliminated by excretion in the urine, 24-h urine
specimens were collected over the first 8 days
after cell wall injection, and samples were as-
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INHIBITOR (log, A g/ml)
FIG. 2. Inhibition studies with anti-cell wall RIAs.
Standard amounts of cell wall were tested in the
presence of varying concentrations of inhibitors. Sym-
bols: 0, A polysaccharide; *, A-variant polysaccha-
ride; tA, D-ala-D-ala; l, rhamnose; and 0, N-acetyl-D-
glucosamine. (A) A polysaccharide RIA; (B) A-variant
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DAYS POST CHALLENGE
FIG. 3. Urinary excretion of streptococcal cell wall
as measured by RIA. We collected 24-h urines from
injected rats on days 0, 1, 2, 3, 4, and 8. Symbols: 0,
100S; A, 10OP; and 0, 10P. Urine from control rats
was negative.
saccharide assay are shown in Fig. 3. The peak
rate of excretion occurred in the first 2 days after
cell wall injection and was less than 1 ,ug per
day. Thereafter, excretion gradually decreased
until day 8, when the total excreted over 24 h
was less than 10% of that seen on day 2. At no
time was the amount detected in urine more than
a minute fraction of the amount injected. Mea-
surement of urinary cell wall with the anti-A-
variant assay gave comparable results (not
shown). Interpretation of results with the anti-D-
ala assay was difficult because of the high back-
ground seen on day 0, representing presumably
nonstreptococcal bacterial contamination (data
not shown).
Analysis of cell wail material over time. Table 2
shows the results of quantitation of tissue cell
wall for the 100S fraction at three time points,
using all three antibody assays. Figure 4 depicts
similar data obtained with the anti-A assay for
all three cell wall preparations. The persistence
of cell wall material over time was further ana-
lyzed by the method of orthogonal polynomials
(17). This statistical approach compares the
slope of the plots of cell wall over time, and
thereby detects differences in the rates of catab-
olism as determined by the parameters being
compared. The influence of the following varia-
bles was assessed: body part (liver, spleen, front
paw, hind paw); assay specificity (anti-A, anti-
D-ala, and anti-A-variant); and cell wall fraction
(lOP, lOOP, and 100S). Nearly all combinations
showed a significant linear decrease of cell wall
material with time. The chief exception was the
lOOP fraction, which showed no significant de-
crease in the liver by the anti-A-variant and anti-
D-ala assays and in the spleen by all three assays
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(Fig. 4). The catabolism curves with the different
variable combinations were compared statisti- Cr
cally. The lOOS fraction, as detected by the anti- g a
A assay, decreased more rapidly in the front and c r X X
hind joints than the lOOP fraction. The same
trend was seen in the liver and spleen, but
statistical analysis could not be made because ONoC 00 00
the slope of the lOOP line was horizontal in these o- 0%
tissues. Regarding body parts, the cell wall I+It1; 3
behaved similarly in the front compared with >p p po
hind joints and in the liver compared with the
spleen. However, the lOOS material had a statis-
tically faster rate of decline in the joints com- -< oo 0000
pared with the liver and spleen by the D-ala %o \Qoe 3
assay. A similar trend was seen with lOOP prepa- 1+- 1+I *a >
ration, but statistical comparison again could not top po a'
be made in most cases. Comparison of the nc
different assays indicated that in the liver and
paws the A epitope decreased more rapidly than 0% 00 w .
the A-variant epitope. However, in general, the "o wo E2
quantitative results with the three RIAs con- + 1+ 1+ 1+
firmed one another. Linear regression analysis
of the results of individual rat joints calculated
separately for days 4, 29, and 65 for all three 9
combinations of the three assays taken two at a ffi 8
CA,time revealed a highly significant (P < 0.001) o
relationship in each case. I+ I+ I+ 1+
Correlation of joint score with cel waUl persis- § o o
tence. The course of clinical arthritis in the
groups of rats injected with the three cell wall
preparations in the current experiments is Po SP0
shown in Fig. 5. The general pattern is similar to
what we had previously observed (6), although o o o o 0
there are certain differences with these groups of o - ox
rats and this particular preparation of cell wall a. o
fragments (for example in the current experi-
ments, there was more acute arthritis with the %9090
J
I
lOP and lOOP preparations than we had previ- T x v .
ously seen). For days 4, 29, and 65, linear It ptptI+
regression analysis of the joint score of an o
individual joint versus the quantity of cell wall in
that same joint was performed by combining the
data from rats injected with the three cell wall
preparations. The regression coefficients ob- o o J 0
tained with each assay at day 4, 29, and 65 are I l+ It
presented in Table 3. In addition, the results
obtained with the anti-A polysaccharide assay 0 0Ox 1
are depicted in Fig. 6. Joint score and cell wall
correlated strongly on day 4. Although a correla-
tion persisted with anti-A and anti-A-variant v 00 ' .
assays on day 29 and 65, the regression coeffi- o p po
cients were progressively lower. av
DISCUSSION
We have documented the persistence of strep- > w 00
tococcal cell wall material in the joints and other >
tissues of rats injected with a single arthropathic o o p o
dose of each of three sizes of cell wall fragments.
The RIAs that we used were highly sensitive and
specific. We found no problem with nonspecific
VOL. 38, 1982










4 29 65 4 29 65
DAYS POST CHALLENGE
FIG. 4. Persistence of streptococcal cell wall in
rats organs. Total organ cell wall was determined by
anti-A polysaccharide RIA from rats sacrificed on
days 4, 29, and 65. Symbols: 0, 100S; A, 100P; and O,
lop.
factors in tissue homogenates. The high back-
ground seen in the assay of urines with the anti-
D-ala assay almost certainly indicates specific





DAY AFTER CELL WALL INJECTION
FIG. 5. Meanjoint score (total of41legs, maximum
score is 16) over time after intraperitoneal injection of
cell wall preparations representing three size ranges of
particles (30 ,ug of rhamnose per g of body weight).
The level of significance (± standard error) among the
three groups was calculated for each day that the
scores were recorded. For clarity in the graph, the
standard error of the mean (bars) was indicated only at
5-day intervals. Fraction 100P (intermediate frag-
ments, A\) was significantly different (P < 0.05) from
fraction 100S (small fragments, 0) at days 59 to 62,
and lOP (large fragments, Li) is different from 100S at
days 1 to 35. There were initially 16 rats per group; 4
rats were killed at day 4, 4 rats were killed at day 29,
and the remaining 8 rats were killed at day 65 for
measurement of cell wall antigen in tissue.
TABLE 3. Correlation of joint score with cell wall
deposition in individual paws
Day after cell wall injection
Assay 4 29 65
at P r P r P
anti-A 0.848a <0.001 0.612 <0.01 0.448 <0.01
anti-A- 0.839 <0.001 0.667 <0.001 0.387 <0.01
variant
anti-D-ala 0.820 <0.001 0.486 <0.05 0.186 >0.2
a Linear regression analysis was by least squares.
terial contamination of the urine samples. All
bacterial cell walls contain peptidoglycan, and
nearly all peptidoglycans have 20 to 70% non-
cross-linked pentapeptide side chains terminat-
ing in the D-ala-D-ala moiety, which our assay
detects. Although part of the terminal D-ala
residues are lost in the process of cell wall cross-
linking, it would be expected that at least some
of these epitopes would be found in every bacte-
rial cell wall. In fact, in other studies (unpub-
lished data), we have found that the anti-D-ala
assay indeed detects material from a variety of
gram-positive and gram-negative bacteria.
The specificity of the anti-A-variant assay
deserves some comment. A-variant polysaccha-
ride was used to affinity purify antibody for this
assay, whereas the anti-A and anti-D-ala anti-
bodies were purified with synthetic haptens. The
A-variant differs from the A polysaccharide by
loss of almost all terminal side chain NADG
moieties (3). Others have shown that anti-A-
variant antisera are inhibited by oligosaccha-
rides derived from this polymer, but not at all by
high concentrations of monomeric rhamnose
(13, 16), in accord with our results. The partial
inhibition of the A-variant assay with NADG
may indicate some NADG moieties in the A-
variant polysaccharide, either as residual side
chain ends or inserted in the polyrhamnose
backbone (14). The NADG could cross-react
with some other as yet undetermined epitope. It
is also probable that the A-variant polysaccha-
ride used to purify the antibody for this assay
was contaminated with peptidoglycan, since it
partially inhibited the D-ala assay (Fig. 2C).
Accordingly, antiglycan backbone reactivities
could have been copurified with the anti-A-
variant antibody, and these might recognize
NADG.
Application of our assays to rat cell wall-
induced arthritis has elucidated several of the
quantitative aspects of this model. After intra-
peritoneal injection, the streptococcal cell wall
material was disseminated to a variety of organs,
but mostly to the liver and the spleen. The cell
wall was slowly metabolized so that it persisted
throughout the course of the experiment, partic-
INFECT. IMMUN.





























k ate fragments) were deposited in the joints, in
0 O O/ parallel with the greater acute disease seen with
the former preparation (Fig. 4 and 5). Over time,
A A however, the 100P preparation was more slowly
A/. metabolized, reflecting the increased chronic
arthritis seen with these larger particles. The 10P
preparation (largest fragments) was distributed
in substantially lower quantities to the joints, in
accord with the much smaller amount of arthritis
seen in this case. Additionally, the increased
metabolism of the A (NADG) epitope in the liver
and paws of 100S-injected rats, compared with
the A-variant epitope, suggests that a 3-glucosa-
_______,_____ ,______ ,_____ ,____ minidase may slowly remove the terminal
O 2 3 NADG, as has been previously reported in rab-
JOINT bit and mouse tissue (19, 20).
~ We have not yet accounted for the bulk of the
injected cell wall material. About 10% of it is
found in the organs that we surveyed at 4 days
D
0 0 after injection. It is possible that a great deal of it. ^ °Ois catabolized in the first 3 days after injection.
However, as the amount detected in the urine
during this time was less than 1 ,ug per day, the
catabolism must either involve excretion by
another route (e.g., feces) or breakdown to
fragments too small to be detected in our assays.
It is likewise possible that much of the material
persists in body regions that we have not yet
tested, such as the lymph nodes, the peritoneal
O 2 3 cavity, or skin.
JOINT SCORE An important finding was that the degree of
clinical arthritis in an individual joint correlated
A with the amount of cell wall material deposited
A A, ^ ^ * ^ in that joint. This correlation was most strong on
day 4 and became progressively weaker on days
Ao. 0 29 and 65. These results are consistent with the* * . 0 hypothesis that the cell wall material is directly
toxic to the joints, and that therefore more cell
wall means more inflammation. Since other fac-
tors, such as complement, undoubtedly play a
role in the chronic disease, it is not surprising
,_______,______ ,______ ,____________ that the degree of correlation of cell wall concen-O
J
2 3 4 tration with inflammation decreases with time.
There is one caveat to these interpretations. OurJ. 6. Relationship of degree of arthritis to quan- correlations were done by pooling data fromfcell wall in individual joints. The clinical joint eahof were ce bypoong da yis plotted against the total joint cell wall as each of the three cell wall preparations. On day
nined by the anti-A polysaccharide RIA. Open 4,uced100S preparation localized most efficientlyDls represent hind paws, and closed symbols to the joints and induced the most arthritis; this
sent front paws. Symbols: 0 and*, 1OOS; A and might not be a causal relationship. These two
OP; andO and U, 10P. (A) Day 4 after cell wall findings could be separately related to a third
ion, (B) day 29, and (C) day 65. Lines shown are unknown factor specific for that 100S prepara-
by least-squares analysis. Correlation coeffi- tion; or they could be associated only by chance.
are given in Table 3. Since there was not enough spread of quantity of
cell wall in joints within a group of rats injected
with a preparation of one cell wall size, it was
in the liver and spleen. The general distri- impossible to show significant regression with-
tn of the three cell wall fractions used out pooling the data.
-ted the course of joint disease with these The restriction of clinical disease in this rat
ions. Initially, somewhat larger amounts of model to the joints can not be explained by a
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tissues compared with other body parts (Table
1). Indeed, the presence of cell wall in liver and
spleen is associated with acute and chronic
inflammatory changes (4, 5). The reaction in the
liver is characterized by the absence of necrosis,
the localization of antigen in the Kupfer cells,
and the formation of small granulomata which
do not appear to effect hepatic function. The
lesions in the spleen and lymph node are charac-
terized initially by focal necrosis and hemor-
rhage, followed by the accumulation of macro-
phages containing cell wall antigens. Immune
dysfunctions observed in the rats (Schwab, in
press) may be related to these histological
changes in the lymphoid tissue.
The results presented raise questions that are
now approachable with our quantitative technol-
ogy. What, for example, is the mechanism of
distribution of cell wall material after intraperi-
toneal injection? It could be transported through
the blood, although we found very little cell wall
in the blood at a given time. It is possible that its
distribution depends on low levels of natural
antibodies, complement, or both, although other
studies indicate that complement is probably not
involved in the initial distribution of the cell wall
(18a). Another important question is the mecha-
nism of catabolism of the cell wall. Much of it
appears to be contained in macrophages based
on immunohistological staining (5). It is un-
known whether the cell wall is eventually de-
stroyed within the phagocytic vacuoles, egested
and broken down extracellularly, or excreted
by, for example, the enterohepatic circulation.
Ginsburg et al. have addressed this important
question of the precise nature of bacterial degra-
dation, and their extensive studies have been
recently reviewed (7). It is also not clear wheth-
er the material we detect in the tissues is repre-
sentative of the injected cell wall. Since the
cleanest cell wall preparations are still heteroge-
neous in terms of particle size, it is possible that
a special subfraction may be most effective in
mediating the tissue inflammation. Finally, we
do not yet have any information as to whether
the tissue-associated cell wall is bound to any
host proteins that might be important in mediat-
ing inflammation. The cell wall is known to
activate complement (8), and it would not be
surprising to find C3 covalently bound to the
peptidoglycan components (15). In addition,
antibody to the various cell wall epitopes is
produced in the arthritic rats (9) and may form
immune complexes in vivo. These lines of inves-
tigation are currently being pursued with the
quantitative methods described here.
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